Immune thrombocytopenic purpura among the children attending at two teaching hospitals

Md Golam Hafiz1, M A Mannan, Syed Khairul Amin

  • 1Department of Pediatric Hematology and Oncology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh.

Insights

Immune thrombocytopenic purpura (ITP) in children shows a summer peak incidence. Management varies, with observation for some and treatments like corticosteroids for others, highlighting seasonal trends in pediatric ITP.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Clinical Research

Background:

  • Immune thrombocytopenic purpura (ITP) is an autoimmune disorder affecting platelet counts.
  • Understanding ITP's clinical features and management in children is crucial for effective care.
  • Seasonal variations in ITP incidence may influence diagnostic and treatment strategies.

Purpose of the Study:

  • To evaluate the presenting features, diagnosis, seasonal variation, and management of immune thrombocytopenic purpura (ITP) in children.
  • To identify any seasonal predilection for ITP in pediatric populations.
  • To analyze the different management approaches employed for pediatric ITP.

Main Methods:

  • Retrospective evaluation of 110 children diagnosed with ITP at two tertiary hospitals.
  • Analysis of presenting features, diagnostic workup, and treatment protocols.
  • Assessment of seasonal incidence patterns and patient outcomes.

Main Results:

  • A peak incidence of pediatric ITP was observed during summer months (June, July), with the lowest incidence in autumn/winter (October-December).
  • The mean initial platelet count was 65.5 x 10(9)/L.
  • 35 children were managed with observation, while 75 received treatments including intravenous immunoglobulin and corticosteroids; two cases of intracranial hemorrhage were reported.

Conclusions:

  • ITP in children exhibits a seasonal predilection, with a higher incidence during summer.
  • Management approaches for pediatric ITP are variable, ranging from observation to active pharmacological treatment.
  • Further research into seasonal influences on ITP pathogenesis and outcomes is warranted.